The Bond Market Is Telling Oracle's Stock Analysts Something They Don't Want to Hear
Published on 07/30/2026 at 05:40 | Redaktion boerse-global.de
Oracle's stock closed at 102.64 euros on Wednesday, down 2.71 percent, hovering just above the 52-week low of 100.76 euros hit just days earlier. The decline extends a punishing stretch that has wiped 38.24 percent from the share price since January and 52.58 percent over the past twelve months. Yet the company still commands a market capitalization of 303.65 billion euros.
That is only half the story. The other half is unfolding in a corner of the market most retail investors never watch — and it is far more alarming.
Credit default swaps on Oracle have surged past 215 basis points, meaning it now costs roughly four times more to insure against an Oracle default than the average investment-grade company, where CDS premiums sit around 53 basis points. Microsoft and Alphabet trade in line with that average. Oracle is the outlier, and for reasons that have nothing to do with its headline numbers.
The company ended fiscal 2026 with a backlog of 638 billion dollars, half of which comes from a single multi-year computing agreement with OpenAI announced in early June. That deal is a triumph of salesmanship. But delivering on it requires building data centers, buying chips, and signing energy contracts at a scale that has turned Oracle from a capital-light software house into a capital-hungry infrastructure operator — and the balance sheet is buckling under the weight.
Should investors sell immediately? Or is it worth buying Oracle?
Oracle spent 55.7 billion dollars on data centers and infrastructure in fiscal 2026. The result was a negative free cash flow of 23.7 billion dollars. Total debt stands at roughly 130 billion dollars. S&P Global responded on July 9 by downgrading Oracle to BBB-, the lowest rung of investment grade. Moody's followed on July 24 with a warning about cash flow risks and a negative outlook.
The rating downgrade has real-world consequences. In Wisconsin, regulators demanded a 100 million dollar deposit for new data center projects because Oracle's credit rating had fallen below the A- threshold. That is a signal that reaches beyond the balance sheet and into day-to-day operations.
Bondholders are already voting with their wallets. The yield on Oracle's 2054 bonds has climbed a full percentage point over the past year to 7.8 percent. For the fiscal year 2027, Oracle plans to raise roughly 40 billion dollars through new debt or equity offerings to close an expected free cash flow gap of 42 billion dollars. The question is whether that gap gets filled through shareholder dilution or higher interest costs — or both.
A quarterly dividend of 0.50 US dollars per share, most recently ex-dividend on July 10, 2026, offers a gesture of continuity. But it does nothing to address the fundamental tension at the heart of Oracle's strategy: the company must invest aggressively to work through its massive backlog, yet those very investments are weakening its financial foundation. The more Oracle builds, the more expensive building becomes.
Even good news is getting buried. A software contract with the U.S. Department of Defense, announced on July 23, barely registered with a market fixated on the balance sheet.
Oracle at a turning point? This analysis reveals what investors need to know now.
Technically, Oracle looks oversold. The 14-day RSI sits at 31.3, and the stock trades nearly 29 percent below its 50-day moving average. The annualized volatility over the past 30 trading days is approaching 47 percent. Those are classic setups for a bounce. But oversold does not mean safe.
What makes this moment unusual is the gulf between the stock market and the credit market. The average analyst price target for Oracle stands at 217.90 euros — more than double the current share price. Equity analysts see a growth story trading at a roughly 40 percent discount. Bond traders see the highest default risk in years. Both are looking at the same company, but they are pricing different time horizons. Analysts are valuing the long-term substance of the backlog. The market is pricing the short-term cash bleed.
The coming quarters will determine whether Oracle's AI bet pays off — whether the revenue from those massive contracts can outrun the interest costs and capital spending required to deliver them. Until that equation becomes clear, Oracle remains a case study in how expensive the transformation to AI infrastructure can be, and how loudly the bond market can shout when the stock market refuses to listen.
Ad
Oracle Stock: New Analysis - 30 July
Fresh Oracle information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
